What's New

The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years

A study exploring the many health benefits of the first 8 years of LF elimination efforts was published in PLoS NTDs in October 2008. The Global Programme to Eliminate LF has so far prevented 6.6 million children from acquiring the disease and stopped another 9.5 million people already infected from progressing to more debilitating stages.

For more information and for full-text access, please visit our Publications page.

 

 

‘Past, Present and Future Partnerships in Disease Elimination and Eradication'

A meeting co-hosted by The Carter Center and GlaxoSmithKline on disease elimination partnerships was held in Atlanta on December 4th, 2008. A full report from the meeting can be found here.

Video excerpts can be viewed on the GlaxoSmithKline website at the following address: http://www.gsk.com/community/filariasis/carter-center.htm.

 

 

Stop LF Public Service Announcement

Click on the screen below to view the Global Alliance to Eliminate LF’s new Public Service Announcement.

 

 

Newsletters

Activities Update—Issue 1 (July 2007)
Activities Update—Issue 2 (July 2008)

 

 

We Want Your Work - PLoS Neglected Tropical Diseases - www.plosntds.org

Announcing a new online journal, PLoS Neglected Tropical Diseases

PLoS (Public Library of Science), the open-access publisher of high-quality peer-reviewed online journals, launched PLoS Neglected Tropical Diseases in 2007. All PLoS articles are freely available online for you to use and share in any way you choose, and the copyright remains where it belongs—with the author.

This journal focuses on the scientific, medical and public-health aspects of these forgotten diseases affecting the world’s forgotten people. Authors and readers benefit from:

  • Fast publication – a seamless electronic workflow quickly puts articles online
  • Wide dissemination – open access democratizes science making it globally available
  • Barrier-free communication – frequently leads to great media coverage
  • Access in perpetuity – automatic deposit in PubMed Central ensures availability forever
  • No subscription fees – means everyone can read and enjoy research